They can see the probable benefit (quick, cheap and more accurate which puts less strain on clinic and hospital resources, hence cost) of using the device ResAppDx outweigh the risk.......
Ann: ResApp Builds European Market Presence, page-95
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
